lamivudine has been researched along with isothiafludine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, F; Jia, H; Jiang, X; Liang, X; Liu, N; Liu, X; Ma, C; Zhan, P | 1 |
| Cherukupalli, S; Du, X; Jia, H; Liu, X; Yu, J; Zhan, P | 1 |
2 other study(ies) available for lamivudine and isothiafludine
| Article | Year |
|---|---|
Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
Topics: Antiviral Agents; Drug Design; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Inhibitory Concentration 50; Pyrazoles; Structure-Activity Relationship | 2016 |
Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Topics: Antiviral Agents; Capsid Proteins; Dose-Response Relationship, Drug; Drug Design; Hepatitis B e Antigens; Hepatitis B virus; Microbial Sensitivity Tests; Molecular Structure; Pyrazines; Pyrazoles; Pyridines; Pyrimidines; Structure-Activity Relationship; Thiazoles; Virus Replication | 2020 |